Association Between Uncontrolled Diabetes and Development of Mucormycosis in COVID-19 Patients
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.88 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Aakanksha Tapadiya und 2 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Coronavirus disease 2019 (COVID-19) has been associated with several complications, among which COVID-19-associated mucormycosis is a rare but severe invasive fungal infection. Caused by Mucorales species, it predominantly affects immunocompromised individuals and is associated with high morbidity and mortality, especially when diagnosis and treatment are delayed.
Aims
To evaluate the association between uncontrolled diabetes and the development of mucormycosis in patients with COVID-19, and to assess the role of poor glycaemic control as a major risk factor for COVID-19associated mucormycosis.
Methods
This was a hospital-based observational study conducted at Dr. VithalraoVikhe Patil’s Foundation Medical College and Hospital, Ahilyanagar, Maharashtra, over a one-year period from January 2021 to December 2022. The study included 100 patients diagnosed with COVID-19 who were evaluated for mucormycosis during the study period and fulfilled the inclusion criteria.
Result
Among the 100 study participants, most were aged 41–60 years (46%) and were predominantly male (68%). Uncontrolled diabetes was the most common glycaemic status (62%). Mucormycosis occurred significantly more frequently in patients with uncontrolled diabetes (90.3%) compared to those with controlled diabetes (42.9%) and newly detected diabetes (80%), demonstrating a highly significant association between poor glycaemic control and the development of mucormycosis (p < 0.001).
Conclusion
The study demonstrates that poor glycaemic control and steroid use are strongly associated with mucormycosis, with middle-aged and elderly males being most affected. Uncontrolled diabetes was identified as the primary risk factor, highlighting the critical role of chronic hyperglycaemia in the development of the infection.
Zitieren
APA
Tapadiya, A., Tapadiya, G., & Tapadiya, A. (2026). Association Between Uncontrolled Diabetes and Development of Mucormycosis in COVID-19 Patients. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.88
Vancouver
Tapadiya A, Tapadiya G, Tapadiya A. Association Between Uncontrolled Diabetes and Development of Mucormycosis in COVID-19 Patients. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.88
BibTeX
@article{Tapadiya2026,
author = {Tapadiya, Aakanksha and Tapadiya, Girish and Tapadiya, Archana},
title = {Association Between Uncontrolled Diabetes and Development of Mucormycosis in COVID-19 Patients},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.88}
}
EUVIMED